These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25371807)

  • 41. Extended spectrum -lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility pattern in a tertiary care hospital.
    Babypadmini S; Appalaraju B
    Indian J Med Microbiol; 2004; 22(3):172-4. PubMed ID: 17642726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial susceptibility pattern of extended-spectrum beta- lactamase producing Klebsiella pneumoniae clinical isolates in an Indian tertiary hospital.
    Singh AK; Jain S; Kumar D; Singh RP; Bhatt H
    J Res Pharm Pract; 2015; 4(3):153-9. PubMed ID: 26312255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics.
    Sekowska A; Janicka G; Kłyszejko C; Wojda M; Wróblewski M; Szymankiewicz M
    Med Sci Monit; 2002 Mar; 8(3):BR100-4. PubMed ID: 11889457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carriage of Class 1 and 2 Integrons in Quinolone, Extended-Spectrum-β-Lactamase-Producing and Multi Drug Resistant E.coli and K.pneumoniae: High Burden of Antibiotic Resistance.
    Shams F; Hasani A; Ahangarzadeh Rezaee M; Nahaie MR; Hasani A; Soroush Bar Haghi MH; Pormohammad A; Elli Arbatan A
    Adv Pharm Bull; 2015 Sep; 5(3):335-42. PubMed ID: 26504755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fecal Carriage Rate of Extended-Spectrum Beta-Lactamase-Producing
    Diriba K; Awulachew E; Tekele L; Ashuro Z
    Infect Drug Resist; 2020; 13():3791-3800. PubMed ID: 33122924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cross-class resistance to non-beta-lactam antimicrobials in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
    Procop GW; Tuohy MJ; Wilson DA; Williams D; Hadziyannis E; Hall GS
    Am J Clin Pathol; 2003 Aug; 120(2):265-7. PubMed ID: 12931557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibiotic combination as empirical therapy for extended spectrum Beta-lactamase.
    Al-Muharrmi Z; Rafay A; Balkhair A; Jabri AA
    Oman Med J; 2008 Apr; 23(2):78-81. PubMed ID: 22379542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran.
    Shahcheraghi F; Moezi H; Feizabadi MM
    Med Sci Monit; 2007 Nov; 13(11):BR247-250. PubMed ID: 17968291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae from Riyadh, Saudi Arabia.
    Al-Qahtani AA; Al-Agamy MH; Ali MS; Al-Ahdal MN; Aljohi MA; Shibl AM
    J Chemother; 2014 Jun; 26(3):139-45. PubMed ID: 24091155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CTX-M-15 in combination with aac(6')-Ib-cr is the most prevalent mechanism of resistance both in Escherichia coli and Klebsiella pneumoniae, including K. pneumoniae ST258, in an ICU in Uruguay.
    Bado I; Gutiérrez C; García-Fulgueiras V; Cordeiro NF; Araújo Pirez L; Seija V; Bazet C; Rieppi G; Vignoli R
    J Glob Antimicrob Resist; 2016 Sep; 6():5-9. PubMed ID: 27530831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of Enterobacteriaceae isolates obtained from a tertiary care hospital in Mexico, which produces extended-spectrum β-lactamase.
    Morfín-Otero R; Mendoza-Olazarán S; Silva-Sánchez J; Rodríguez-Noriega E; Laca-Díaz J; Tinoco-Carrillo P; Petersen L; López P; Reyna-Flores F; Alcantar-Curiel D; Garza-Ramos U; Garza-González E
    Microb Drug Resist; 2013 Oct; 19(5):378-83. PubMed ID: 23725513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
    P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Occurrence of extended-spectrum beta-lactamase in clinical isolates of Klebsiella pneumoniae in a University Hospital, Thailand.
    Kusum M; Wongwanich S; Dhiraputra C; Pongpech P; Naenna P
    J Med Assoc Thai; 2004 Sep; 87(9):1029-33. PubMed ID: 15516002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at Armed Forces Hospital in Saudi Arabia.
    Ahmad S; Al-Juaid NF; Alenzi FQ; Mattar EH; Bakheet Oel-S
    J Coll Physicians Surg Pak; 2009 Apr; 19(4):264-5. PubMed ID: 19356348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.